1373554-98-3

Upstream product

• 1373555-60-2 C₃₂H₃₂O₁₁S 
• 1103738-19-7 ((3aS,5R,6S,6aS)-6-hydroxy-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-5-yl)(morpholin-4-yl)methanone 
• 1373555-61-3 C₃₁H₃₂O₉S₂ 
• 1373555-59-9 C₂₇H₂₆O₇S 
• 1373555-99-7 C₁₉H₁₅IO₂S 

Relevant academic research and scientific papers

C-ARYL GLUCOSIDE DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF

The present invention relates to a C-aryl glucoside derivative of Formula (I) below, a preparation method therefor and a use thereof, wherein X, R1, R2, R3, R4, m and n are as defined in specification. The deriv

C-ARYLGLUCOSIDE DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF

The present invention relates to a C-aryl glucoside derivative of Formula (I) below, a preparation method therefor and a use thereof, wherein X, R1, R2, R3, R4, m and n are as defined in specification. The derivative of the present invention is a sodium-glucose co-transporter 2 (SGLT-2) inhibitor associated with glucose reabsorption of bowel or kidney, and has a good urine glucose excreting effect, thus being useful as a therapeutic agent for treating diabetes and related diseases.